Hemolysis: a harbinger of adverse outcome after left ventricular assist device implant.

@article{Cowger2014HemolysisAH,
  title={Hemolysis: a harbinger of adverse outcome after left ventricular assist device implant.},
  author={Jennifer Ann Cowger and Matthew A Romano and Palak Mayur Shah and Neha D Shah and Vivek M Mehta and Jonathan William Haft and Keith David Aaronson and Francis D. Pagani},
  journal={The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation},
  year={2014},
  volume={33 1},
  pages={35-43}
}
BACKGROUND The clinical relevance of elevated serum markers of hemolysis during left ventricular assist device (LVAD) support has not been fully ascertained. METHODS Lactate dehydrogenase (LDH) and serum free hemoglobin (sfHg) values were tallied monthly in 182 patients on HeartMate II (Thoratec, Pleasanton, CA) LVAD support. Peak values for each marker were identified, and 2 hemolysis definitions were applied to the cohort: Hemolysis according to Interagency Registry for Mechanically… CONTINUE READING